Financhill
Back

Nuvalent Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell
45

NUVL
Nuvalent

Last Price:
95.49
Seasonality Move:
-4.53%
Buy
100

RYTM
Rhythm Pharmaceuticals

Last Price:
67.31
Seasonality Move:
9.98%
Sell
45
Nuvalent (NUVL) is a Sell

Is Nuvalent a Buy, Sell or Hold?

  • The current Nuvalent [NUVL] share price is $95.42. The Score for NUVL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NUVL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

NUVL Stock Price Chart

What is Nuvalent's stock price today?

  • The Nuvalent share price today is $95.42
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUVL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $67.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

NUVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 50.63 Buy
Chaikin Money Flow: 232194 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.41 - 103.03) Sell
Bollinger Bands (100): (75.25 - 98.31) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.14 Buy
Relative Strength Index (14 RSI): 81.29 Buy
Chaikin Money Flow: 966983 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.36 - 56.78) Buy
Bollinger Bands (100): (43.87 - 52.87) Buy

NUVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.62 Buy
20-day SMA: 95.8 Sell
50-day SMA: 96.38 Sell
200-day SMA: 80.96 Buy
8-day EMA: 93.18 Buy
20-day EMA: 94.68 Buy
50-day EMA: 93.69 Buy
200-day EMA: 80.84 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.18 Buy
20-day SMA: 52.43 Buy
50-day SMA: 50.91 Buy
200-day SMA: 45.07 Buy
8-day EMA: 58.59 Buy
20-day EMA: 54.14 Buy
50-day EMA: 51.2 Buy
200-day EMA: 44.61 Buy

Nuvalent Earnings Growth & NUVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.18 per share, and a decrease next year of $0.83 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.

Nuvalent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):